Nanophotosensitive drugs for light-based cancer therapy: what does the future hold?

NANOMEDICINE

FUTURE MEDICINE LTD

1. National Institutes of Health [U54 CA199092, R01 EB021048, R01 CA171651, P50 CA094056, P30 CA091842, S10 OD016237, S10 RR031625, S10 OD020129]
2. Department of Defense Breast Cancer Research Program [W81XWH-16-1-0286]
3. Alvin J Siteman Cancer Research Fund [11-FY16-01]